Akebia to Host Conference Call on November 7, 2024, at 8:00
a.m. EST
CAMBRIDGE, Mass., Nov. 1, 2024
/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today
announced plans to release its financial results for the third
quarter ended September 30, 2024, on
Thursday, November 7, 2024, prior to
the open of financial markets.
Akebia will host a conference call on Thursday, November 7, 2024, at 8:00 a.m. EST to discuss its financial results
and recent business highlights. To access the call, please register
by clicking on this Registration Link, and you will be provided
with dial in details. To avoid delays and ensure timely connection,
we encourage dialing into the conference call 15 minutes ahead of
the scheduled start time.
A live webcast of the conference call will be available via the
Investors section of Akebia's website at: https://ir.akebia.com/.
An online archive of the webcast can be accessed via the Investors
section of Akebia's website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. Akebia was
founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-third-quarter-2024-financial-results-and-discuss-recent-business-highlights-302293581.html
SOURCE Akebia Therapeutics, Inc.
